918
- Poseida Therapeutics, $110M with Schonfeld Strategic Advisors, Fidelity, and Adage Capital Management
- Artiva Biotherapeutics, $78M with 5AM Ventures, venBio Partners, RA Capital Management, and Medivate Partners, among others
- ClickUp, $35M with Craft Ventures and Georgian Partners
- Sun Genomics, $8.65M with Pangaea Ventures
- Carlsmed, $2.5M with Wavemaker Three-Sixty Health and Device of Tomorrow Capital, among others
- GroupSolver, $2M with Eterus Capital and Tech Coast Angels, among others
- Engrail Therapeutics, $32M with Nan Fung Life Sciences
- Lassen Therapeutics, $31M with Longwood Funds, Frazier Healthcare Partners, and Alta Partners
- Upcycle & Co, $825K with Tech Coast Angels, among others
- Cue, $100M with Madrone Capital Partners, Johnson & Johnson Innovation – JJDC, Foresite Capital, Decheng Capital, and ACME Capital
- Autobahn Therapeutics, $76M with Section 32, Samsara BioCapital, Pfizer Venture Investments, Invus, Cowen Healthcare Investments, Bristol-Myers Squibb, Biotechnology Value Fund, Biogen Idec, Alexandria Venture Investments, and ARCH Venture Partners
- Lycia Therapeutics, $50M with Versant Ventures
- Glysens, $15M with Mcnair Interests and The Sarofim Group
- Quidel, $635K with Biomedical Advanced Research and Development Authority
- Viacyte, $27M with Sanderling Ventures, Bain Capital Life Sciences, TPG Capital, and RA Capital Management
- Gali Health, $3M with Tech Coast Angels San Diego, Felicis Ventures, BOLD Capital Partners, and Bob Nelson, among others
- Simply Independent, $300k with Launch Factory
- Ascus Biosciences, $46M with Temasek Holdings, Formation 8, Cavallo Ventures, and Anterra Capital
- Platform Science, $42M with Schematic Ventures, Prologis, NewRoad Capital Partners, Daimler Trucks North America, Cambridge Capital, and 8VC
- CalciMedica, $15M with Valence Life Sciences, Sanderling Ventures, Mesa Verde Venture Partners, and Bearing Capital
- Amplyx, $90M with Sofinnova Investments, New Enterprise Associates, Lundbeckfonden Ventures, Arix Bioscience, Pappas Capital, RiverVest Venture Partners, 3×5 Partner s , BioMed Ventures, and Adage Capital Management
- Ecwid, $42M with PeakSpan Capital and Morgan Stanley Expansion Capital
- Chromacode, $10M with Adjuvant Capital
- Alume Biosciences, $5.5M with Dan Bradbury and Chrysa Mineo
- Plantible Foods, $4.6M with Vectr, Lerer Hippeau, FTW Ventures, and Eighteen94 Capital
- Redemption Games, amount undisclosed with AppLovin
- Erasca, $200M with ARCH Venture Partners, Cormorant Asset Management, EDBI, Terra Magnum Capital Partners, LifeSci Venture Partners, Colt Ventures, City Hill Ventures, and Invus
- Brain Cor p, $36M with SoftBank Vision Fund 1, ClearBridge Investments, Satwik Ventures, and Qualcomm Ventures
- Trovata, $4.3M with JP Morgan and FINTOP Capital
- Intellecy, $125K with undisclosed investors
- Aspen Neuroscience, $70M with OrbiMed, Section 32, Sam Altman, Frazier Healthcare Partners, Domain Associates, and ARCH Venture Partners
- AristaMD, $18M with Stanford Health Care, The CU Healthcare Innovation Fund, MemorialCare Innovation Fund, Cigna Ventures, and Avalon Ventures
- Cue, $13M with Biomedical Advanced Research and Development Autho
- Design Therapeutics, $45M with SR One, Cormorant Asset Management, Quan Capital and West River Group
- FLX Bike, $1.3M via crowdfunding equity
